Biblical Archaeology’s Top 10 Discoveries of 2019
A glimpse at the important excavation work revealed this year.
Related Articles
Bryan Johnson discontinues longevity drug, after concerns it may have accelerated aging | – Times of India
Bryan Johnson, a tech entrepreneur, has stopped using rapamycin, a drug not approved for anti-aging by the FDA, following concerns it may have aged hi
Why Are Recurring Dreams Usually Nightmares?
Recurring dreams may feature taking a test the dreamer didn’t study for, having to make a speech or being attacked. Here’s why our sleeping brain…
JPM25: Vertex CEO says pain is its next multi-billion franchise
Vertex’s leaders projected confidence in the firm’s non-opioid pain franchise at the JP Morgan Healthcare Conference on Monday, although the first cut of data for…
HHS publishes AI Strategic Plan, with guidance for healthcare, public
The framework explores ways to spur innovation and adoption, enable more trustworthy model development, promote access and foster AI-empowered healthcare workforces.
Public Sharing of Adverse Events of Gene Therapy Trials
This Viewpoint describes the need for public sharing of adverse events associated with genetic therapies to improve patient safety.
Geographical Disparities in Research Misconduct: Analyzing Retraction Patterns by Country
This study examines disparities in research retractions due to misconduct, identifying countries with the highest retraction counts and those disproportionately represented relative to population and…
Regeneron Collaborates with Truveta and Leading American Health Systems to Massively Extend its DNA Sequence-Linked Healthcare Database to Further Advance Scientific Innovation and Healthcare Delivery | Regeneron Pharmaceuticals Inc.
The Truveta collaboration will extend Regeneron Genetics Center’s ® (RGC TM ) world-leading DNA sequence-linked healthcare database (now including almost three million de-identified patient volunteers)…
Illumina and NVIDIA collaborate to decode biology and propel precision health
/PRNewswire/ — Illumina, Inc. (NASDAQ: ILMN), a global leader in genomic sequencing and analysis, today announced it is collaborating with NVIDIA to advance…
Neuron type-specific mRNA translation programs provide a gateway for memory consolidation.
Long-term memory consolidation is a dynamic process that requires a heterogeneous ensemble of neurons, each with a highly specialized molecular environment. Considerable effort has been…
Vertex on the Verge of Breakthrough for Nonopioid Pain Management as NOPAIN Act Takes Effect
Suzetrigine, the investigational selective NaV1.8 pain signal inhibitor, with a PDUFA date of Jan 30, could become a first-in-class nonopioid analgesic.